World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
50190
World Ranking
6434
National Ranking
205

Roberto Latini publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Roberto Latini sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 679 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Roberto Latini D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Roberto Latini sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Roberto Latini is affiliated with the Mario Negri Institute for Pharmacological Research in Italy. Their research primarily focuses on the field of medicine, with a significant concentration on cardiology and cardiovascular medicine, accounting for 81 publications. Other subfields of study include neurology, molecular biology, epidemiology, and emergency medicine.

Their work addresses several key topics related to cardiovascular health and associated medical conditions. These main research areas include:

  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Cardiac Arrest and Resuscitation
  • Vascular Malformations Diagnosis and Treatment
  • Sepsis Diagnosis and Treatment
  • GDF15 and Related Biomarkers
  • Cardiac Imaging and Diagnostics

Roberto Latini has published extensively in notable scientific venues. Frequent publication outlets include:

  • European Heart Journal
  • ESC Heart Failure
  • European Journal of Clinical Investigation
  • Zenodo (CERN European Organization for Nuclear Research)
  • The Lancet

Selected recent papers demonstrate a range of research interests and collaborative efforts. Some of the publications include:

  • Understanding the Complex of Suicide in Depression: from Research to Clinics, 2020, Psychiatry Investigation
  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials, 2022, The Lancet
  • The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial, 2020, European Heart Journal
  • Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS, 2021, Critical Care
  • Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis, 2024, The Lancet Diabetes & Endocrinology

Collaborative research is an important component of Roberto Latini's work. Frequent co-authors include:

  • Jennifer Meessen
  • Deborah Novelli
  • Lidia Staszewsky
  • Aldo P. Maggioni
  • Giuseppe Ristagno

Best Publications

  • Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research

    Andrew I R Maas;David K Menon;P David Adelson;Nada Andelic

  • A trial of goal- oriented hemodynamic therapy in critically ill patients

    L Gattinoni;L Brazzi;P Pelosi;R Latini

  • Effect of prone positioning on the survival of patients with acute respiratory failure

    Luciano G. Gattinoni;Gianni Tognoni;Antonio Pesenti;Paolo Taccone

  • Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

    R. S. McKelvie;S. Yusuf;D. Pericak;A. Avezum

  • Albumin Replacement in Patients with Severe Sepsis or Septic Shock

    Pietro Caironi;Gianni Tognoni;Serge Masson;Roberto Fumagalli

  • Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

    Inder S. Anand;Lloyd D. Fisher;Yann Tong Chiang;Roberto Latini

  • Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure

    Roberto Latini;Roberto Latini;Serge Masson;Inder S. Anand;Emil Missov

  • Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor

    Michael Brines;Giovanni Grasso;Giovanni Grasso;Fabio Fiordaliso;Alessandra Sfacteria

  • Indications for ACE inhibitors in the early treatment of acute myocardial infarction - Systematic overview of individual data from 100,000 patients in randomized trials

    M G Franzosi;E Santoro;G Zuanetti;C Baigent

  • Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

    Laura Calvillo;Roberto Latini;Jan Kajstura;Annarosa Leri

  • Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis.

    Sachin Sud;Jan O. Friedrich;Jan O. Friedrich;Paolo Taccone;Federico Polli

  • Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trial.

    Paolo Taccone;Antonio Pesenti;Roberto Latini;Federico Polli

  • C-Reactive Protein in Heart Failure Prognostic Value and the Effect of Valsartan

    Inder S. Anand;Roberto Latini;Roberto Latini;Viorel G. Florea;Michael A. Kuskowski

  • Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

    Aldo P. Maggioni;Roberto Latini;Peter E. Carson;Steven N. Singh

  • Valsartan for Prevention of Recurrent Atrial Fibrillation

    Gissi-Af Investigators;Marcello Disertori;Roberto Latini;Simona Barlera

  • PTX3, A Prototypical Long Pentraxin, Is an Early Indicator of Acute Myocardial Infarction in Humans

    Giuseppe Peri;Martino Introna;Domenico Corradi;Giuseppe Iacuitti

  • Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction

    Roberto Latini;Aldo P. Maggioni;Giuseppe Peri;Lucio Gonzini

  • Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors.

    Aldo P Maggioni;Inder Anand;Sidney O Gottlieb;Roberto Latini

  • Disruption of the Ang II type 1 receptor promotes longevity in mice

    Ariela Benigni;Daniela Corna;Carla Zoja;Aurelio Sonzogni

  • Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure

    John J.V. McMurray;Bertram Pitt;Roberto Latini;Aldo P. Maggioni

Frequent Co-Authors

Aldo P. Maggioni
Aldo P. Maggioni Heart Care Foundation, ANMCO Research Center, Florence
Gianni Tognoni
Gianni Tognoni University of Milan
Luigi Tavazzi
Luigi Tavazzi University of Ferrara
Jay N. Cohn
Jay N. Cohn University of Minnesota
Antonio Pesenti
Antonio Pesenti University of Milan
Luciano Gattinoni
Luciano Gattinoni University of Göttingen
Inder S. Anand
Inder S. Anand University of Minnesota
Alberto Mantovani
Alberto Mantovani Humanitas University
Thor Ueland
Thor Ueland University of Oslo
John J.V. McMurray
John J.V. McMurray University of Glasgow

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but want alternative or supplemental career options, there are multiple online degrees to consider. For those passionate about diet, wellness, and prevention, a bachelor's in nutrition online can lead to diverse roles in healthcare, counseling, and public health.

Aspiring healthcare leaders may prefer cahme accredited online mha programs, which prepare students for management roles in hospitals and health systems. These master’s programs focus on policy, administration, and organizational leadership within healthcare environments.

Current nurses can advance by enrolling in online rn to bsn programs no clinicals, which allow registered nurses to earn a Bachelor of Science in Nursing without additional on-site requirements. This flexible pathway opens doors to advanced practice and supervisory positions.

For nurses aiming to quickly earn the highest clinical degree, accelerated dnp programs offer a fast-track to becoming a Doctor of Nursing Practice. This route is ideal for those seeking leadership or specialized clinical roles with greater autonomy.

Best Scientists Citing Roberto Latini

Trending Scientists

Recently Published Articles